Clinical Trials Browser

INDUSTRY × Biliary Tract Neoplasms × surufatinib × Clear all

NCT03873532 2020-02-13

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Phase 2/3 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT02966821 2019-02-27

Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms